Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?

Current Opinion in Lipidology

Volumn 11, Issue 6, 2000, Pages 603-607

  Steinberg, Daniel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAUSE OF DEATH; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROKE; THROMBOSIS;

ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; CORONARY DISEASE; HUMANS; LIPOXYGENASE; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; SPECIES SPECIFICITY; THROMBOSIS; VITAMIN E;

ANIMALIA;

EID: 0033675223     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200012000-00006     Document Type: Review

References (43)

1. Antioxidants and atherosclerosis: A current assessment
2. The role of oxidized lipoproteins in atherogenesis
3. Pathogenesis of atherosclerosis
4. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis
5. Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice
6. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse
7. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice
8. Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice
9. Antiatherogenic effects of the antioxidant BO-653 in three different animal models
10. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritabte hyperlipidemic rabbit
11. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia
12. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?
13. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice
14. Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice
15. 2 mimics cell-mediated oxidative modification
16. Lipoperoxides in LDL incubated with fibreblasts that overexpress 15-lipoxygenase
17. Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase
18. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions
19. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apoE-deficient mice
20. At last, direct evidence that lipoxygenases play a role in etherogenesis
21. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
22. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
23. Scavenger receptor deficiency leads to more complex etherosclerotic lesions in apoE3 Leiden transgenic mice
24. Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation
25. Vitamin E, a modifier of platelet function: Rationale and use in cardiovascular and cerebrovascular disease
26. Alpha-tocopherol down-regulates scavenger receptor activity in macrophages
27. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes
28. Vitamin E improves arterial compliance in middle-aged men and women
29. Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: A randomized, factorial design, placebo-controlled trial
30. Vitamin E supplementation in hyperlipidemic patients: Effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation
31. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
32. The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial
33. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
34. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
35. Dietary supplementation with n-3 polyunsaturated fatty acids and Vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
36. Clinical trials of antioxidants in atherosclerosis: Are we doing the right thing?
37. George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal
38. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and followup of preclinical atherosclerosis in living human subjects
39. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering
40. Antioxidants in the prevention of human atherosclerosis. Summary of the Proceedings of a National Heart, Lung, and Blood Institute Workshop, September 5-6, 1991, Bethesda, Maryland
41. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasma and cardiovascular disease
42. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
43. Comparison of the efficiencies of several natural and synthetic antioxidants in aqueous SDS micelle solutions